» Go to news main
Zebrafish lead Dalhousie researchers to important discoveries in prostate cancer and leukemia
The zebrafish, a four- to six-centimetre minnow, has led researchers to remarkable revelations about the development and treatment of human disease.
These include a surprising discovery about prostate cancer, and a hopeful one for childhood leukemia, in studies led by Dr. Graham Dellaire and Dr. Jason Berman at Dalhousie.
Dr. Dellaire’s main interest is the treatment of solid tumours found in breast, lung and prostate cancer. He sees zebrafish as an important vehicle for developing personalized cancer therapies.
“If we can inject the embryo with cells from a human tumour and then introduce a range of chemotherapy treatments, we can figure out which one works best for a particular patient,” he says.
Read more on Dal News.
Recent News
- Celebrating 10 Years of Dalhousie’s Medical Sciences program
- Global impact: Three Dal faculty recognized in 2024 Highly Cited Researchers list
- Student offers simple skills on how to quickly improve care for people with sight loss
- Three Dal researchers nominated for this year's Public Impact Award
- Dal student triumphs at Falling Walls in Berlin
- One in five kids endure chronic pain. A new pain standard will soothe it
- The healing power of exercise in cancer treatment
- Dalhousie surgeons pioneering colonoscopy training